Other Preserving the Brain: A Call to Action

16-10-2024 to
07-04-2025 Add to iCal
Other Fondazione Prada in Milan
Poster of the Exhibition Preserving the Brain
Poster of the Exhibition Preserving the Brain Photo: Fondazione Prada

The new edition of “Preserving the Brain,” part of the “Human Brains” project dedicated since 2018 to neurosciences, focuses on the preventionof neurodegenerative diseases. Organized inpartnership with fifteen renowned neuroscienceinstitutes from world-class universities and five Italian patient organizations and associations,“Preserving the Brain: A Call to Action” consists in a scientific conference and an exhibition which will be accompanied by a series of meetings.

“Preserving the Brain: A Call to Action” aims to focus on the importance of prevention and early treatment of widespread and still incurable diseases,such as Alzheimer’s, Huntington’s, Parkinson’s, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis. Neurodegenerative diseases are characterized by a series of modifiable risk factors, the correction of which would have major consequences on an individual and collective level. To protect ourselves from the increasing prevalence of these diseases,it is crucial to act on modifiable risk factors, take care of the environment, promote healthy lifestyles, implement educational activities, and engageall actors of society and political institutions. 

Preventive health

The impressive recent development of genetic and biological markers for all these diseases also allows to identify individuals who are at risk for a specific disease, and the activation of secondary prevention strategies that could include the implementation of specific therapies.

For this reason, the project sees the participation of leading research centers, academics, patient associations, and organizations that operate in the field of brain health, as well as representatives of institutions. The main goal is a productive exchange among different stakeholders to promote specific actions related to modifiable factors on neurodegenerative diseases, leading up to a “call to action” addressed to a wide population, especially younger generations.

Institutes involved in the project 

  • Harvard Medical School, Brigham and Women’s Hospital, Ann Romney Center for Neurological Diseases, Boston, United States
  • Hôpital de la Pitié-Salpêtrière, Sorbonne University AP-HP,Neurology department and Paris Brain Institute, Paris, France
  • UniSR – Università Vita-Salute San Raffaele, Milan, Italy
  • Juntendo University Hospital, Neurology Department, Tokyo,Japan
  • Karolinska Institutet, Stockholm, Sweden
  • German Center for Neurodegenerative Diseases (DZNE)within the Helmholtz Association, Bonn, Germany
  • Max Planck Institute of Neurobiology, Munich, Germany
  • Montreal Neurological Institute-Hospital, McGill Research andTeaching Institute, Canada
  • Multiple Sclerosis Centre of Catalonia, Vall d’Hebron UniversityHospital, Barcelona, Spain;Tianjin Medical University General Hospital, NeurologyDepartment, Tianjin, China
  • UCSF Weill Institute for Neuroscience, University of California,San Francisco, United States
  • University College London, United Kingdom
  • University Medical Centers, Amsterdam, Netherlands;Weizmann Institute of Science, Revohot, Israel
  • Yale School of Medicine, New Haven, United States.